Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Research and Development Grants

McGill University

$112,000.00

Automatic segmentation of healthy tissues and tumours in patient brain images using 3D fully convolutional neural networks

EF 2017-18

Résumé
It is estimated that over 55,000 Canadians are currently living with a brain tumour. Patients with gliomas, the most frequent primary brain tumour in adults, still have very poor prognosis despite considerable advances in research. High-grade glioma patients have a median life expectancy of two years or less, and low-grade gliomas come with a life expectancy of several years. In either case, neuroimaging protocols are employed before and after treatment in order to estimate disease progression, surgical planning and effect. Current clinical protocol involves analysis of the patient images by a radiologist, where rudimentary qualitative and quantitative metrics are employed, such as the manual measurements of tumour size, a process that is time-consuming, subjective and potentially inconsistent. The goals of this project are to develop robust, accurate and fully automatic tissue segmentation techniques that can identify both healthy and diseased tissues when applied to real, multimodal, clinical MRI, with the long-term potential benefit of improving patient diagnosis, surgical planning and follow-up. This includes the development of new machine learning (e.g. deep learning) techniques to accurately detect and segment (1) tumours into their constituent sub-structures (e.g. tumour core, edema) and (2) healthy tissues (e.g. white matter) in multi-channel patient MRI. Although deep learning frameworks have been incredibly successful at a wide variety of tasks in computer vision, their adaptation to medical image detection and segmentation, particularly of pathological structures, is still in its infancy. This is due to a multitude of new challenges presented in the context of noisy, multi-modal 3D images, and to a shortage of large-scale datasets required for training. Medical image analysis research would benefit from the development of new mathematical models and analytical tools that could potentially improve patient care and outcome, including the savings in time and the improvement in accuracy of pre-surgical planning and post-operative follow-up.
Programme
Collaborative Research and Development Grants
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
505357-2016
Name nom
Arbel, Tal
Department département
Electrical and Computer Engineering
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2016
Award amount
112000
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1 & 2
Nb partie
2
Application title
Automatic segmentation of healthy tissues and tumours in patient brain images using 3D fully convolutional neural networks
Keyword
NSERC
Application summary
It is estimated that over 55,000 Canadians are currently living with a brain tumour. Patients with gliomas, the most frequent primary brain tumour in adults, still have very poor prognosis despite considerable advances in research. High-grade glioma patients have a median life expectancy of two years or less, and low-grade gliomas come with a life expectancy of several years. In either case, neuroimaging protocols are employed before and after treatment in order to estimate disease progression, surgical planning and effect. Current clinical protocol involves analysis of the patient images by a radiologist, where rudimentary qualitative and quantitative metrics are employed, such as the manual measurements of tumour size, a process that is time-consuming, subjective and potentially inconsistent. The goals of this project are to develop robust, accurate and fully automatic tissue segmentation techniques that can identify both healthy and diseased tissues when applied to real, multimodal, clinical MRI, with the long-term potential benefit of improving patient diagnosis, surgical planning and follow-up. This includes the development of new machine learning (e.g. deep learning) techniques to accurately detect and segment (1) tumours into their constituent sub-structures (e.g. tumour core, edema) and (2) healthy tissues (e.g. white matter) in multi-channel patient MRI. Although deep learning frameworks have been incredibly successful at a wide variety of tasks in computer vision, their adaptation to medical image detection and segmentation, particularly of pathological structures, is still in its infancy. This is due to a multitude of new challenges presented in the context of noisy, multi-modal 3D images, and to a shortage of large-scale datasets required for training. Medical image analysis research would benefit from the development of new mathematical models and analytical tools that could potentially improve patient care and outcome, including the savings in time and the improvement in accuracy of pre-surgical planning and post-operative follow-up.